2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
April 4th, 2025
Version: 1
University of Manchester
cancer biology
biorxiv

Hypoxia-induced extracellular matrix changes are conserved in cancer and directly impact radiotherapy benefit

Guerrero Quiles, C.Open in Google Scholar•Gonzalez Abalos, J.Open in Google Scholar•Foussat, A. S.Open in Google Scholar•Olympitis, A.Open in Google Scholar•Lodhi, T.Open in Google Scholar•Smith, V.Open in Google Scholar•Reardon, M.Open in Google Scholar•Shabbir, R.Open in Google Scholar•Lunj, S.Open in Google Scholar•Reeves, K.Open in Google Scholaret al.

Our overarching aim was to determine how hypoxia affects the extracellular matrix (ECM). Transcriptomic analysis (21,941 patients; 10 cancer types) identified ECM remodelling as the predominant pathway affected by hypoxia. Multi-omics confirmed that hypoxia impacts ECM organisation and collagen degradation; 53 ECM genes were affected, of which 74% were HIF1/HIF2-regulated. Spatial transcriptomics highlighted different hypoxia remodelling processes in tumour and stroma. Five ECM genes commonly affected in tumour and in vitro constituted a signature. This signature was independently prognostic and independently predictive of radiotherapy benefit in multiple malignancies. Patients within either high or low hypoxic-ECM score tertiles benefited from radiotherapy versus surgery. Hypoxic ECMs generated in vitro increased adhesion and decreased migration of cancer cells, an effect enhanced by irradiation. Immunofluorescence demonstrated that hypoxia decreased collagen fibre number, and irradiation decreased cell-ECM interactions. Taken together, these findings demonstrate hypoxia induces pan-cancer ECM changes, directly impacting radiotherapy benefit.

Similar Papers

biorxiv
Fri Apr 04 2025
Mapping the spatial architecture of glioblastoma from core to edge delineates niche-specific tumor cell states and intercellular interactions
Treatment resistance in glioblastoma (GBM) is largely driven by the extensive multi-level heterogeneity that typifies this disease. Despite significant progress toward elucidating GBM\'s genomic and transcriptional heterogeneity, a critical knowledge gap remains in defining this heterogeneity at the spatial level. To address this, we employed spatial transcriptomics to map the architecture of the ...
Khan, S. M.
•
Wang, A. Z.
•
Desai, R. R.
•
McCornack, C. R.
...•
Petti, A. A.
biorxiv
Fri Apr 04 2025
Differential Adaptation and Remodeling of the Tumor Microenvironment in Breast Cancer Cells During the Stages of Brain Metastasis
Objective To integrate macro-transcriptomics and single-cell sequencing to analyze the differential gene expression between primary and brain metastatic breast cancer cells, as well as between active and dormant cancer cells within brain metastases, exploring their adaptation and remodeling abilities at different stages of brain metastasis. Methods Four public datasets were used: three mRNA microa...
Wu, X.
•
Zhang, Y.
•
Huang, Z.
•
Li, R.
biorxiv
Fri Apr 04 2025
Single cell spatial transcriptomics identifies coordinated cellular programs associated with good prognosis in microsatellite stable colorectal cancer
It has been reported that microsatellite instable (MSI) tumors in colorectal cancer (CRC) exhibit stronger anti-tumor immune responses than microsatellite stable (MSS) tumors. Using a simple classification system we recently showed that MSS tumors with both high numbers of tumor-associated macrophages (TAMs) and T cells had good prognosis, whereas high numbers of TAMs and low numbers of T cells ha...
Karlsen, V. T.
•
Majid, U.
•
Lindholm, H. T.
•
Umu, S. U.
...•
Jahnsen, F. L.
biorxiv
Thu Apr 03 2025
An LC-MS/MS method for the quantification of tobacco-specific carcinogen protein adducts.
4-(Methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its major metabolite 4- (methylnitrosamino)-l-(3-pyridine)-l-butanol (NNAL) are tobacco-specific lung carcinogens. Methods have been developed to quantify NNK- and NNAL-specific DNA adducts in pre-clinical samples but are less feasible to translation due to limited access to target tissues for sufficient DNA. NNAL-specific DNA or protein ad...
Xing, C.
•
Freeman, B. N.
biorxiv
Thu Apr 03 2025
Single cell spatial transcriptomics identifies coordinated cellular programs that are associated with good prognosis in microsatellite stable colorectal cancer
It has been reported that microsatellite instable (MSI) tumors in colorectal cancer (CRC) exhibit stronger anti-tumor immune responses than microsatellite stable (MSS) tumors. Using a simple classification system we recently showed that MSS tumors with both high numbers of tumor-associated macrophages (TAMs) and T cells had good prognosis, whereas high numbers of TAMs and low numbers of T cells ha...
Karlsen, V. T.
•
Majid, U.
•
Lindholm, H. T.
•
Umu, S. U.
...•
Jahnsen, F. L.
biorxiv
Thu Apr 03 2025
Discovery and therapeutic exploitation of Master Regulatory miRNAs in Glioblastoma
Glioblastoma is a fatal primary malignant brain tumor. Despite therapies involving surgical resection, chemotherapy, and radiation therapy, the average survival for glioblastoma patients remains at approximately 15 months. MicroRNAs (miRNAs) are short noncoding RNA molecules that regulate the expression of the majority of human genes. Numerous genes are concurrently deregulated in glioblastoma. Co...
Abounader, R.
•
Saha, S.
•
Zhang, Y.
•
Gibert, M. K.
...•
Hafner, M.
biorxiv
Thu Apr 03 2025
Presence of Hepatitis B virus infection in colon cancer
Hepatitis B virus (HBV) infection affects ~300 million people worldwide, which population is at an elevated risk of various cancers, such as gastrointestinal cancer, while the matter behind is largely unclear. In this study, we analyzed 10 colonic specimens from 6 colon cancer patients who were also chronic HBV carriers through Fluorescence-activated Cell Sorting and Immunofluorescence assay to in...
Li, L.
•
Gong, W.
•
An, Y.
•
Tong, H.
...•
Sun, K.
biorxiv
Thu Apr 03 2025
Epitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug Conjugates
Antibody-drug conjugates (ADCs) targeting cell surface proteins TROP2 or HER2 are effective in metastatic breast cancer, but the precise clinical contribution of epitope expression is uncertain. We prospectively monitored circulating tumor cells (CTCs) in 33 patients receiving ADC therapies using quantitative imaging. The expression of TROP2 and HER2 are heterogeneous across single CTCs from untre...
Mishra, A.
•
Abelman, R.
•
Cunneely, Q.
•
Putaturo, V.
...•
Maheswaran, S.
biorxiv
Thu Apr 03 2025
WEE1 inhibitors trigger GCN2-mediated activation of the integrated stress response
The WEE1 kinase negatively regulates CDK1/2 to control DNA replication and mitotic entry. Genetic factors that determine sensitivity to WEE1 inhibitors (WEE1i) are largely unknown. A genome-wide insertional mutagenesis screen revealed that mutation of EIF2A, a translation regulator, sensitized to WEE1i. Mechanistically, WEE1i treatment triggers a translational shut-down, which is lethal in combina...
Tjeerdsma, R. B.
•
Ng, T.
•
Roorda, M.
•
Bianchi, D.
...•
van Vugt, M.